BNP Paribas Financial Markets Portfolio holdings
BNP Paribas Financial Markets, a core component of BNP Paribas’s Corporate & Institutional Banking (CIB) division, is a global leader in trading and market-making, headquartered in Paris with major hubs in London, New York, Hong Kong, and Singapore. Specializing in derivatives across all asset classes—equities, fixed income, commodities, and foreign exchange—it provides innovative investment, hedging, and financing solutions to corporate clients, institutional investors, and financial institutions worldwide. Known for its advanced technological infrastructure and quantitative expertise, the division excels in structured financing and electronic trading, supported by a robust balance sheet and a diversified business model that proved resilient during the 2008 financial crisis. With a presence in over 50 countries and a client base exceeding 13,000, BNP Paribas Financial Markets drives market liquidity and offers cutting-edge research and execution services, reinforcing its position as a top-tier player in global capital markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$344M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$266M |
| 3 |
Motorola Solutions
MSI
|
+$224M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$222M |
| 5 |
State Street SPDR S&P Biotech ETF
XBI
|
+$210M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$235M |
| 2 |
Alibaba
BABA
|
+$199M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$195M |
| 4 |
iShares MSCI Emerging Markets ETF
EEM
|
+$132M |
| 5 |
APC
Anadarko Petroleum
APC
|
+$122M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 8.31% |
| 2 | Financials | 6.96% |
| 3 | Consumer Discretionary | 5.46% |
| 4 | Healthcare | 4.97% |
| 5 | Industrials | 4.04% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
VIA
3826
DELISTED
Via Renewables, Inc. Class A Common Stock
VIA
| $19.6K | ﹤0.01% |
371
+102
| +38% | +$5.38K |
|
|
DNBF
3827
DELISTED
DNB Financial Corp
DNBF
| $19.6K | ﹤0.01% |
440
+275
| +167% | +$12K |
|
3828
Flotek Industries
FTK
$1.35B
| $19.6K | ﹤0.01% |
1,483
-7
| -0.5% | -$107 |
|
3829
Barnes & Noble Education
BNED
$417M
| $19.6K | ﹤0.01% |
63
-28
| -31% | -$9.8K |
|
|
EMWP
3830
DELISTED
Eros Media World PLC
EMWP
| $19.5K | ﹤0.01% |
511
+236
| +86% | +$8.38K |
|
|
CHNG
3831
DELISTED
Change Healthcare Inc. Common Stock
CHNG
| $19.5K | ﹤0.01% |
+1,612
| New | +$22.1K |
|
|
VAPO
3832
DELISTED
Vapotherm, Inc. Common Stock
VAPO
| $19.2K | ﹤0.01% |
253
+185
| +272% | +$21.5K |
|
3833
Alico
ALCO
$308M
| $19.2K | ﹤0.01% |
564
+11
| +2% | +$349 |
|
|
THOR
3834
DELISTED
Synthorx, Inc. Common Stock
THOR
| $19.2K | ﹤0.01% |
1,179
+320
| +37% | +$5.35K |
|
3835
Saga Communications
SGA
$64.6M
| $19.1K | ﹤0.01% |
643
+16
| +3% | +$478 |
|
3836
CorMedix
CRMD
$557M
| $19.1K | ﹤0.01% |
2,995
+2,929
| +4,438% | +$24.6K |
|
|
RLH
3837
DELISTED
Red Lions Hotel Corporation
RLH
| $19.1K | ﹤0.01% |
2,944
+41
| +1% | +$256 |
|
3838
Syndax Pharmaceuticals
SNDX
$1.77B
| $19.1K | ﹤0.01% |
2,552
+904
| +55% | +$8.23K |
|
3839
Escalade
ESCA
$284M
| $19.1K | ﹤0.01% |
1,750
+22
| +1% | +$241 |
|
3840
HSBC
HSBC
$358B
| $19K | ﹤0.01% |
496
+139
| +39% | +$5.39K |
|
3841
Oak Valley Bancorp
OVLY
$283M
| $18.9K | ﹤0.01% |
1,129
+24
| +2% | +$431 |
|
3842
Alphatec Holdings
ATEC
$1.49B
| $18.9K | ﹤0.01% |
3,771
+3,563
| +1,713% | +$18.5K |
|
3843
MainStreet Bancshares
MNSB
$177M
| $18.9K | ﹤0.01% |
897
+555
| +162% | +$12.1K |
|
3844
Kiniksa Pharmaceuticals
KNSA
$6.1B
| $18.9K | ﹤0.01% |
2,216
+679
| +44% | +$7.5K |
|
|
ZYXI
3845
DELISTED
Zynex
ZYXI
| $18.8K | ﹤0.01% |
2,178
+2,134
| +4,850% | +$17.4K |
|
|
MSON
3846
DELISTED
Misonix Inc
MSON
| $18.8K | ﹤0.01% |
935
+916
| +4,821% | +$19.8K |
|
3847
Vanguard Information Technology ETF
VGT
$149B
| $18.8K | ﹤0.01% |
696
| – | – |
|
|
DLA
3848
DELISTED
Delta Apparel Inc.
DLA
| $18.6K | ﹤0.01% |
784
+475
| +154% | +$10.5K |
|
|
MMAC
3849
DELISTED
MMA Capital Holdings, Inc. Common Stock
MMAC
| $18.6K | ﹤0.01% |
620
+383
| +162% | +$11.7K |
|
|
ADMS
3850
DELISTED
Adamas Pharmaceuticals
ADMS
| $18.5K | ﹤0.01% |
3,611
+1,100
| +44% | +$6.79K |
|
Similar funds
BNP Paribas Financial Markets's Q3 2019 Portfolio in Review
As of Q3 2019, BNP Paribas Financial Markets held 4,631 positions worth $56.3B, up 12% from $50.2B the previous quarter. Its ten largest holdings account for 15% of the portfolio.
BNP Paribas Financial Markets deployed $1.76B of net new capital in Q3 2019, opening 103 new positions and adding to 2,522 existing holdings. Its largest new stake was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
By sector, the portfolio is most concentrated in Technology at 8.3% of assets, down from 8.5% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was Apple, an estimated $235M trimmed.
- BNP Paribas Financial Markets's largest Q3 2019 buy was VanEck Pharmaceutical ETF: 400,000 shares worth $22.8M.
- BNP Paribas Financial Markets added most to Visa in Q3 2019, an estimated $344M increase.
- BNP Paribas Financial Markets's biggest Q3 2019 reduction was Apple, cutting an estimated $235M.
- BNP Paribas Financial Markets fully exited Anadarko Petroleum in Q3 2019, selling an estimated $122M.
- BNP Paribas Financial Markets's ten largest holdings make up 15% of its $56.3B portfolio in Q3 2019.
- BNP Paribas Financial Markets opened 103 new positions and closed 116 in Q3 2019.
- BNP Paribas Financial Markets's portfolio value rose 12% quarter-over-quarter to $56.3B.
Based on BNP Paribas Financial Markets's 13F filing for Q3 2019, filed 7 Nov 2019.